Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02838069
What this trial is testing

A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis

Who this might be right for
Osteoarthritis
University Hospital, Montpellier 100
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Not applicableEnrolling By InvitationNCT06017505
What this trial is testing

Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals

Who this might be right for
DementiaAlzheimer DiseaseMild Cognitive Impairment+1 more
Douglas Scharre 1,486
Not applicableNot Yet RecruitingNCT07753382
What this trial is testing

Effects of Adaptive Difficulty Computerized Cognitive Training on Cognitive Function Improvement in Older Adults With Mild Cognitive Impairment

Who this might be right for
Cognitive Dysfunction, Cognitive DisorderCognitive Training
China Medical University, China 36
Not applicableLooking for participantsNCT05986279
What this trial is testing

Improving Psychological and Vestibular Health: MINDGAPS

Who this might be right for
Vestibular Hypofunction
University of Montana 500
Testing effectiveness (Phase 2)Study completedNCT04504279
What this trial is testing

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 154
Post-approval studies (Phase 4)Study completedNCT04969679
What this trial is testing

Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.

Who this might be right for
Ulcerative Colitis
Kangbuk Samsung Hospital 134
Post-approval studies (Phase 4)Study completedNCT00204542
What this trial is testing

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Who this might be right for
Photosensitivity Disorders
University Hospital Tuebingen 418
Large-scale testing (Phase 3)Ended earlyNCT05242042
What this trial is testing

JT001 (VV116) for the Early Treatment of COVID-19

Who this might be right for
Mild to Moderate COVID-19
Shanghai JunTop Biosciences Co., LTD 381
Testing effectiveness (Phase 2)Study completedNCT00006373
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Not applicableLooking for participantsNCT06703541
What this trial is testing

ADRC Clinical Cohort (Alzheimer's Disease)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentDementia
Duke University 500
Early research (Phase 1)Active Not RecruitingNCT02088645
What this trial is testing

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Who this might be right for
Thyroid Cancer, MedullaryNeuroendocrine Tumor of the Lung Grade 1 and 2Neuroendocrine Tumor of the Thymus Grade 1 and 2+1 more
University Hospital, Basel, Switzerland 24
Testing effectiveness (Phase 2)Study completedNCT02813070
What this trial is testing

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseHealthy
GE Healthcare 70
Not applicableUnknownNCT05569083
What this trial is testing

PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning

Who this might be right for
Cognitive DeclineMild Cognitive ImpairmentAlzheimer Disease
Azienda Ospedaliero-Universitaria Careggi 350
Large-scale testing (Phase 3)Study completedNCT05056883
What this trial is testing

A Phase III Confirmatory Study of K-237

Who this might be right for
Covid19
Kowa Company, Ltd. 1,030
Not applicableActive Not RecruitingNCT07486141
What this trial is testing

Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Capital Medical University 380
Not applicableStudy completedNCT05753241
What this trial is testing

The Relationship Between Allergic Rhinitis and the Risk of Symptom in Patients With Mild COVID-19

Who this might be right for
COVID-19Allergic Rhinitis
qinxiu zhang 1,100
Early research (Phase 1)WithdrawnNCT03752294
What this trial is testing

A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.

Who this might be right for
Mild Cognitive ImpairmentMild Alzheimer's Disease
University of Rhode Island
Not applicableEnded earlyNCT01330277
What this trial is testing

Biomarkers for Hunter Syndrome

Who this might be right for
Hunter SyndromeMucopolysaccharidosis IIHunter's Syndrome, Mild Form+1 more
CENTOGENE GmbH Rostock 11
Next Page